Ritivixibat (A3907) Phase 2 Clinical Trial Results
Safety results for the Phase 2 ritivixibat study (A3907) for PSC have been released.
PSC and GLP-1 Medication for Weight Loss
Exploring the role of GLP-1 medications and what the latest research means for our community.
PiSCATIN study reaches full recruitment milestone
The PiSCATIN study has enrolled 570 participants, moving us closer to potential PSC treatments.
Volunteer Trustees Wanted
Apply to be a Trustee for PSC Support and use your knowledge and skills to help the charity meet the needs of people affected by PSC.
PSC Support Signs Landmark European Declaration to Accelerate Rare Disease Innovation
PSC Support joins European leaders to advocate for a cohesive ecosystem in rare disease care.
February 2026 Research Roundup
A month of leadership growth, breakthrough research, and new milestones in clinical care.
Help Researchers Understand the Impact of Acute Cholangitis
Help researchers understand ‘PSC flares’ by sharing your symptoms in our global survey.
Driving Global Change Through the Patient Voice
New global survey results reveal the significant impact of itch on life with PSC.
